Search
+
    SEARCHED FOR:

    LISTING OF SBI MF

    Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investors

    Emcure Pharmaceuticals has allocated 57.8 lakh equity shares to 48 funds at the upper end of the IPO price band, raising Rs 582.6 crore. The public subscription for the IPO will commence on July 3rd and conclude on July 5th.

    Stanley Lifestyles lists at 34% premium

    The IPO consisted of a fresh issue of ₹200 crore and an offer for sale of 91.3 lakh shares aggregating to ₹337 crore on the upper price band. The offer was subscribed 96.98 times on its final day of bidding on June 25.

    Looking at 4 buckets in auto thematic fund; avoiding auto financiers: Tanmaya Desai, SBI MF

    Fund manager Tanmaya Desai says that SBI MF is not looking at the auto financiers or the logistics companies. But at the same time, the fund does permit him to evaluate up to 20% in some of those stocks which can be a corollary to the auto opportunity in general.

    Infra and defence mutual funds dominate returns chart in first half of 2024

    The first half of 2024 showcased the dominance of infrastructure and defense-based mutual funds in the market. While some international funds faced challenges, strategic investment decisions were crucial. Diverse performances emphasized the need for a well-rounded portfolio strategy to navigate the market effectively.

    MFs cut weight on technology stocks by 170 bps in just 3 months. What are cues for investors?

    In May, several MFs reduced tech stock weights by 0.1%-0.9%, with HSBC making the highest cut at 0.9%. HDFC MF, Mirae, and Franklin Templeton increased weights by up to 0.2%.

    Best aggressive hybrid mutual funds to invest in June 2024

    If you are bothered about the uncertainties and volatility in the market, you can consider investing in aggressive hybrid mutual funds. Mutual fund advisors typically recommend aggressive hybrid fund schemes to ‘conservative’ equity investors to create wealth to achieve their long-term financial goals.

    The Economic Times
    BACK TO TOP